Dear customers, please be informed that our shopping cart will be unavailable between August 21 and September 1, 2014, as we will be making some changes to serve you better. To minimise any possible delivery disruption, we encourage you to make your purchases before August 21. We appreciate your understanding and apologise for any inconvenience.

Wiley
Wiley.com
Print this page Share
E-book

Guidebook for Drug Regulatory Submissions

ISBN: 978-0-470-45617-0
352 pages
February 2009
Guidebook for Drug Regulatory Submissions  (0470456175) cover image

Destined to become every regulatory director's essential desktop companion

rofessionals working to submit major documents to the Food and Drug Administration (FDA) are guaranteed to encounter numerous unexpected and daunting hurdles. Guidebook for Drug Regulatory Submissions offers a readable and clearly written road map for effective submission of documents for required regulatory reviews during drug development.

Demystifying this complex, high-stakes process, author and nationally recognized drug regulation expert Sandy Weinberg presents professionals with authoritative tips, tools, and advice including suggestions for preparation, checklists for submission, an FDA evaluation tool for review, and copies of relevant FDA guidelines.

As well, vital information is provided on the most common types of submissions, including:

  • Meeting Requests
  • Orphan Drug Applications

  • Investigatory New Drug Applications (INDAs)

  • New Drug Applications (NDAs)

  • 505(b)2 NDAs

  • Abbreviated New Drug Applications (ANDAs)

  • Annual Report

This reference also explores the pressures affecting the industry and the general public, as well as how these pressures will change the general nature and specific aspects of the submissions process over the near future. In addition, retired Canadian trade consul and regulatory consultant Carl Rockburne guest-authors a chapter comparing the FDA process to the four other major regulatory environments of Canada, the European Union, Japan, and Australia.

Guidebook for Drug Regulatory Submissions is more than a useful guide—it is an essential tool to be kept on the desk of every regulatory director, submissions manager, vice president of Regulatory Affairs, and Food and Drug Administration reviewer responsible for the process of drug regulatory submissions.

See More
Chapter 1. Ten Rules for Drug Regulatory Submissions.

Chapter 2. FDA Meeting Requests.

Chapter 3. Orphan Drug Applications.

Chapter 4. Investigatory New Drug Applications (INDs).

Chapter 5. New Drug Applications (NDAs).

Chapter 6. 505(b)2 New Drug Applications.

Chapter 7. Abbreviated New Drug Applications (ANDAs).

Chapter 8. Annual Reports.

Chapter 9. International Submissions (Carl A. Rockburne).

Chapter 10. Future Issues in Regulatory Submissions.

See More

SANDY WEINBERG is the former Vice President for Regulatory Affairs and Quality Assurance at Tikvah Therapeutics, Inc., and is now Associate Professor of Health Care Management and Director of the Master in Health Administration Graduate Program at Clayton State University in Atlanta. He has thirty years of experience in the field of drug regulatory affairs and is the author of twelve books, most recently Good Laboratory Practice Regulations, Fourth Edition.

See More
“The Guidebook for Drug Regulatory Submissions offers a readable and clearly written road map for effective submission of documents for required regulatory reviews during drug development.” (Pharmaceutical Outsourcing, April 2009)
See More
Back to Top